Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
L-arabinose-binding protein AraF (also known as ABP) is a periplasmic substrate-binding protein found in Gram-negative bacteria, most notably Escherichia coli. It serves as the primary receptor for L-arabinose in the high-affinity AraFGH ATP-binding cassette (ABC) transport system, facilitating the uptake of this pentose sugar for catabolism (UniProt P02924). AraF binds L-arabinose with high specificity and affinity, undergoing a Venus flytrap conformational change to deliver the ligand to the membrane-bound permease complex (AraGH) (RCSB PDB 1ABE). While primarily a metabolic protein, AraF is a subject of interest in the development of targeted antimicrobial therapies, such as sugar-drug conjugates that exploit bacterial transport systems for selective drug entry (Preprints.org 2026). It is also a model system for studying protein-carbohydrate interactions and the regulation of bacterial transport under oxidative stress, where its function is modulated by the redox state of its cysteine residues (J. Biol. Chem. 2014). This protein should not be confused with the human A-Raf proto-oncogene (ARAF), which is a serine/threonine kinase involved in the MAPK/ERK signaling pathway and a target in oncology (GeneCards).
Substrate binding and delivery to the AraGH permease complex of the ABC transporter system
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on L-arabinose-binding periplasmic protein (AraF) (AraF).